オプションチェーンは、Endavaの株式オプションの主要データを様々な行使価格と満期日で表示します。トレーダーはこの情報を使用して、潜在的な取引を分析し、Endavaの市場センチメントを評価します。.

Endava (NYSE:DAVA) 株価情報, オプションチェーン

ENDAVA PLC- SPON ADR

Endava

Endava is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2006 in the U.K. and it continues to generate the majority of revenue in the U.K. and Europe. Endava's client base is concentrated in the payments and financial services, technology, media, and telecom industries.

Endava plc American Depositary Shares (each representing one Class A Ordinary Share)

Endava PLC

Pony AI Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PONY#NASDAQ">PONY</a>) stock traded lower on Wednesday. <a href="https://www.cnbc.com/2025/05/14/chinese-robotaxi-operator-ponyai-reports-first-fire-no-injuries.html">CNBC </a>reported that one of the company&#8217;s robotaxis <a href="https://www.benzinga.com/25/05/45416148/pony-ai-shares-rise-after-report-of-confidential-hong-kong-ipo-to-fund-robotaxi-expansion">caught on fire.</a>
The Details: The incident occurred in Beijing, with no passengers involved. This marks the first time one of Pony AI&#8217;s robotaxis has caught fire.
Pony AI said one of its fully autonomous vehicles was found to have an abnormal status in Beijing around 9:30 a.m. local time on May 13. Service workers arrived within two minutes, but the vehicle caught fire during the response.
The company has not announced the cause of the fire.
PONY Price Action: PONY AI shares are down 5.68% at $16.93 on Wednesday, according to data from <a href="https://www.benzinga.com/pro/login">Benzinga Pro.</a>
See Also: • <a href="https://www.benzinga.com/25/05/45417156/nvidia-amd-stocks-climb-as-trump-plans-to-ease-ai-chip-export-rules">Nvidia, AMD And Other Chip Stocks Gain As Trump Plans To Ease AI Chip Export Rules</a>
Photo: via Shutterstock

News

Movers

PONY

Pony AI Stock Is Sliding Wednesday: What's Going On?

Challenge Study measured safety, efficacy against infection and symptomatic disease as well as viral shedding
Machine learning analyses identified statistically significant correlates of protection and will be incorporated into the development of Vaxart's second-generation norovirus vaccine candidate, which is being evaluated in a Phase 1 clinical trial

Biotech

General

VXRT

Vaxart Publishes Complete Data From Phase 2b Challenge Study Of First-Generation Oral Pill Norovirus Vaccine Candidate In Science Translational Medicine

WIIM

AGMH

AGM Group shares are trading lower after the company announced a 50-for-1 share consolidation.

AYTU

Aytu BioPharma shares are trading higher after the company reported Q3 financial results and beat its EPS and revenue estimates.

Boot Barn Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BOOT#NYSE">BOOT</a>) reported quarterly earnings of $1.22 per share which missed the analyst consensus estimate of $1.24 by 1.61 percent. This is a 27.08 percent increase over earnings of $0.96 per share from the same period last year. The company reported quarterly sales of $453.75 million which missed the analyst consensus estimate of $458.42 million by 1.02 percent. This is a 16.81 percent increase over sales of $388.46 million the same period last year.

Earnings

Earnings Misses

BOOT

Boot Barn Holdings Q4 GAAP EPS $1.22 Misses $1.24 Estimate, Sales $453.75M Miss $458.42M Estimate

Stock Split

AGM Group Holdings Announces 50 For 1 Share Consolidation

Bank of America Securities analyst Curtis Nagle rerated internet and e-commerce stocks RH (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RH#NYSE">RH</a>) and Wayfair (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/W#NYSE">W</a>) on Wednesday.
Nagle downgraded RH, or Restoration Hardware, to Underperform and <a href="https://www.benzinga.com/quote/RH/analyst-ratings" target="_blank" rel="noreferrer noopener">raised the price target</a> from $144 to $172.
Nagle rerated after the company&#8217;s fourth-quarter 2024 earnings call that also coincided with Liberation Day, primarily on significant margin risk from tariffs and a weaker demand outlook.
Also Read: <a href="https://www.benzinga.com/general/social-media/25/04/44747892/amazon-wayfair-pinterest-win-analyst-backing-due-to-tariff-pause-supply-chain-relief-discretionary-spend-recovery" target="_blank" rel="noreferrer noopener">Amazon, Wayfair, Pinterest Win Analyst Backing Due To Tariff Pause, Supply Chain Relief, Discretionary Spend Recovery</a>
These reduced tariffs remove a substantial overhang to RH sentiment and margins. However, the analyst remained cautious on demand trends throughout the year and noted continued risk to fiscal year guidance, particularly with a weaker outlook for housing and consumer discretionary spending that could offset RH share gains versus peers. Street estimates are at the low end of 2025 guidance but assume a sharp acceleration in 2-year revenue growth trends and over 100bps of gross margin expansion in the second half.
Prior to the US lowering tariff rates across the board, Nagle&#8217;s analysis indicated that full tariffs would significantly weigh on RH&#8217;s operating margins. Even when assuming substantial mitigation efforts and SG&amp;A cuts, the analyst noted tariff costs would be far more manageable.
Despite removing significant tariff headwinds, several key factors kept the analyst cautious on RH. The company reported that demand growth through April 4 (before tariff impacts) plateaued at 17%, while BAC card data &amp; data on luxury home volumes by the National Association of Realtors suggest decelerating quarter-to-date trends for the industry. 
The guidance does not incorporate tariff costs, which could still weigh on second-half gross margins. While RH expects positive free cash flow, most of this will be driven by stockpiled inventory, RH&#8217;s high net leverage at 5 times, and cash interest expense.
Despite several added headwinds, the stock is now near its five-year average of 19 times and effectively back at its pre-fourth-quarter levels. Still, an improved tariff outlook removes a significant overhang on the stock, which Nagle noted will be reflected in the stock&#8217;s multiple.
Nagle raised his RH fiscal 2025 revenue and EBIT by 1.5% and 7.6% to $3.51 billion and $463 million from $3.45 billion and $430 million to reflect a slightly improved tariff outlook. His fiscal 2025 revenue and EBIT estimates are still 0.3% and 5.2% below the Street. For fiscal 2026, he raised his revenue and EBIT by 2.1% and 2.5% to $3.86 billion and $564 million from $3.78 billion and $550 million.
Nagle maintained Wayfair with a Neutral and <a target="_blank" href="https://www.benzinga.com/quote/W/analyst-ratings" rel="noreferrer noopener">raised the price target</a> from&nbsp;$36&nbsp;to&nbsp;$43.
With China tariffs now lowered to 30% (from 145%), Nagle noted tariff-related costs more manageable for Wayfair, particularly since Wayfair likely has the highest sourcing exposure to China within his Online furnishings coverage.
The price target boost reflects higher sector valuation and a de-escalation in tariff rhetoric.
Price Actions: RH stock is down 3.18% at $218.50 at last check Wednesday. W is down 0.25%.
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/25/05/45416148/pony-ai-shares-rise-after-report-of-confidential-hong-kong-ipo-to-fund-robotaxi-expansion" target="_blank" rel="noreferrer noopener">Robotaxi Service Pony AI Stock Falls Despite IPO Buzz &#8211; Here&#8217;s Why</a></li>
</ul>
Image: Shutterstock

Price Target

Reiteration

Analyst Ratings

Trading Ideas

RH Faces Margin Pressure Despite Tariff Relief, Analyst Flags Weaker Housing Demand Ahead

Iris Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IREN#NASDAQ">IREN</a>) reported quarterly sales of $141.20 million which missed the analyst consensus estimate of $159.37 million by 11.40 percent. This is a 159.80 percent increase over sales of $54.35 million the same period last year.

IREN

Iris Energy Q3 Sales $141.20M Miss $159.37M Estimate

SPIR

Spire Global shares are trading higher after the company reported a Q1 revenue beat and announced it won a 10-year U.S. Space Force contract.

Contineum Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNM#NASDAQ">CTNM</a>) reported quarterly losses of $(0.62) per share which missed the analyst consensus estimate of $(0.58) by 6.9 percent. This is a 82.54 percent increase over losses of $(3.55) per share from the same period last year.

CTNM

Contineum Therapeutics Q1 EPS $(0.62) Misses $(0.58) Estimate

Buybacks

Boot Barn Authorized $200M Repurchase Program

Nextracker Acquires Bentek Corporation For $78M In Cash Including Future Contingent Earnout Consideration

Navigator Holdings (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVGS#NYSE">NVGS</a>) reported quarterly earnings of $0.36 per share which beat the analyst consensus estimate of $0.31 by 16.13 percent. This is a 12.5 percent increase over earnings of $0.32 per share from the same period last year. The company reported quarterly sales of $151.41 million which beat the analyst consensus estimate of $146.30 million by 3.49 percent. This is a 12.86 percent increase over sales of $134.16 million the same period last year.

Earnings Beats

NVGS

Navigator Holdings Q1 Adj. EPS $0.36 Beats $0.31 Estimate, Sales $151.41M Beat $146.30M Estimate

Fidelis Insurance Hldgs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIHL#NYSE">FIHL</a>) reported quarterly losses of $(0.41) per share which met the analyst consensus estimate. This is a 155.41 percent decrease over earnings of $0.74 per share from the same period last year. The company reported quarterly sales of $658.40 million which missed the analyst consensus estimate of $927.63 million by 29.02 percent. This is a 26.62 percent increase over sales of $520.00 million the same period last year.

FIHL

Fidelis Insurance Hldgs Q1 Adj. EPS $(0.41), Inline, Sales $658.40M Miss $927.63M Estimate

Encompass Health (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EHC#NYSE">EHC</a>) has outperformed the market over the past 10 years by 2.33% on an annualized basis producing an average annual return of 13.01%. Currently, Encompass Health has a market capitalization of $12.03 billion. 
Buying $1000 In EHC: If an investor had bought $1000 of EHC stock 10 years ago, it would be worth $3,395.37 today based on a price of $119.27 for EHC at the time of writing.
<h3>Encompass Health's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1747253717_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In Encompass Health 10 Years Ago Would Be Worth This Much Today

Oncology Institute (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOI#NASDAQ">TOI</a>) affirms FY2025 sales outlook from $460.00 million-$480.00 million to $460.00 million-$480.00 million vs $482.80 million estimate.

Guidance

Oncology Institute Affirms FY2025 Sales Guidance of $460.00M-$480.00M vs $482.80M Est

RCAT

Red Cat Holdings shares are trading lower after the company reported worse-than-expected Q1 financial results.

<ul>
<li>Most Studies Meeting the Literature Review Criteria Found That a Higher Glucocorticoid Dose was Statistically Significantly Associated with Adverse Clinical Outcomes</li>
<li>Findings Presented at the 2025 International Society for Pharmacoeconomics and Outcomes Research Annual Meeting</li>
</ul>

Events

NBIX

Neurocrine Biosciences Presents Study Showing Relationship Between Higher Glucocorticoid Dose And Adverse Clinical Outcomes

Nortech Systems (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NSYS#NASDAQ">NSYS</a>) reported quarterly losses of $(0.48) per share. This is a 284.62 percent decrease over earnings of $0.26 per share from the same period last year. The company reported $26.89 million in sales this quarter. This is a 21.39 percent decrease over sales of $34.22 million the same period last year.

NSYS

Nortech Systems Q1 EPS $(0.48) Down From $0.26 YoY, Sales $26.89M Down From $34.22M YoY

IBTA

Ibotta shares are trading higher after the company reported better-than-expected Q1 financial results and issued Q2 sales guidance with its midpoint above estimates.

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Endava plc - DAVA

October 25, 2024 Deadline: Contact The Gross Law Firm to Join Class Action Suit Against  DAVA

Endava to Announce Q1 FY2025 Financial Results on November 12, 2024

Endava Announces First Quarter Fiscal Year 2025 Results

Endava to Announce Q2 FY2025 Financial Results on February 20, 2025

Endava Announces Second Quarter Fiscal Year 2025 Results

Endava Pioneers OpenAI's Exclusive Partner Program

Endava to Announce Q3 FY2025 Financial Results on May 14, 2025

Endava and AlixPartners Announce Partnership to Accelerate Digital Transformation

Comments

Endava

Endava (DAVA) オプション

Loading...

ニュース

パートナーシップ

ベンジンガ・グローバル